Research ArticleLaboratory Studies
Enhanced Tumor Specificity of 741F8-1 (sFv′)2, an Anti-c-erbB-2 Single-Chain Fv Dimer, Mediated by Stable Radioiodine Conjugation
Louis M. Weiner, Gregory P. Adams, John E. McCartney, Ellen J. Wolf, Jamie Eisenberg, James S. Huston, Michael A. Bookman, Philip Moldofsky, Walter F. Stafford and L.L. Houston
Journal of Nuclear Medicine December 1995, 36 (12) 2276-2281;
Louis M. Weiner
Gregory P. Adams
John E. McCartney
Ellen J. Wolf
Jamie Eisenberg
James S. Huston
Michael A. Bookman
Philip Moldofsky
Walter F. Stafford III
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Enhanced Tumor Specificity of 741F8-1 (sFv′)2, an Anti-c-erbB-2 Single-Chain Fv Dimer, Mediated by Stable Radioiodine Conjugation
Louis M. Weiner, Gregory P. Adams, John E. McCartney, Ellen J. Wolf, Jamie Eisenberg, James S. Huston, Michael A. Bookman, Philip Moldofsky, Walter F. Stafford, L.L. Houston
Journal of Nuclear Medicine Dec 1995, 36 (12) 2276-2281;
Enhanced Tumor Specificity of 741F8-1 (sFv′)2, an Anti-c-erbB-2 Single-Chain Fv Dimer, Mediated by Stable Radioiodine Conjugation
Louis M. Weiner, Gregory P. Adams, John E. McCartney, Ellen J. Wolf, Jamie Eisenberg, James S. Huston, Michael A. Bookman, Philip Moldofsky, Walter F. Stafford, L.L. Houston
Journal of Nuclear Medicine Dec 1995, 36 (12) 2276-2281;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Avidity-Mediated Enhancement of In vivo Tumor Targeting by Single-Chain Fv Dimers
- Quantitative Immuno-Positron Emission Tomography Imaging of HER2-Positive Tumor Xenografts with an Iodine-124 Labeled Anti-HER2 Diabody
- 125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts